Publications of Gerd Meyer zu Hörste

Fledrich, R.; Schlotter-Weigel, B.; Schnizer, T. J.; Wichert, S. P.; Stassart, R. M.; Meyer zu Hörste, G.; Klink, A.; Weiss, B. G.; Haag, U.; Walter, M. C. et al.; Rautenstrauss, B.; Paulus, W.; Rossner, M. J.; Sereda, M. W.: A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients. Brain 135 (1), pp. 72 - 87 (2012)

Leal, A.; Huehne, K.; Bauer, F.; Sticht, H.; Berger, P.; Suter, U.; Morera, B.; Del Valle, G.; Lupski, J. R.; Ekici, A. et al.; Pasutto, F.; Endele, S.; Barrantes, R.; Berghoff, C.; Neundörfer, B.; Heuss, D.; Dorn, T.; Young, P.; Santolin, L.; Uhlmann, T.; Meisterernst, M.; Sereda, M.; Meyer zu Hörste, G.; Nave, K.-A.; Reis, A.; Rautenstrauss, B.: Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models. Neurogenetics 10 (4), pp. 275 - 287 (2009)

Meyer zu Hörste, G.; Prukop, T.; Liebetanz, D.; Möbius, W.; Nave, K.-A.; Sereda, M. W.: Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy. Annals of Neurology 61 (1), pp. 61 - 72 (2007)

Meyer zu Hörste, G.; Nave, K.-A.: Animal models of inherited neuropathies. Current Opinion in Neurology 19 (5), pp. 464 - 473 (2006)

Meyer zu Hörste, G.; Prukop, T.; Nave, K.-A.; Sereda, M. W.: Myelin disorders: causes and perspectives of Charcot-Marie-Tooth neuropathy. Journal of Molecular Neuroscience 28 (1), pp. 77 - 88 (2006)

Meyer zu Hörste, G.; Sereda, M. W.: Genetische Defekte der Myelinbildung: Molekulare Pathogenese der Charcot-Marie-Tooth Neuropathie (CMT1A). Neuroforum 1, pp. 25 - 30 (2005)

Sereda, M. W.; Meyer zu Hörste, G.; Suter, U.; Uzma, N.; Nave, K.-A.: Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nature Medicine 9 (12), pp. 1533 - 1537 (2003)

Meyer zu Hörste, G.: Therapeutische Anwendung des Progesteronantagonisten "Onapriston" im transgenen Rattenmodell der Charcot-Marie-Tooth-Erkrankung Typ 1A (CMT1A). Dissertation, Georg-August-Universität, Göttingen (2006)